For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@taibsbio.cn
首页 > 组织芯片 > 前列腺 > MPR761a
tissue microarray-MPR761a
  • 点数:
    76
    例数:
    35
    点样直径(mm):
    2
    厚度(µm):
    5
    行数:
    8
    列数:
    10
    组织阵列类型:
    FFPE
    种属:
    Human
MPR761a
加入收藏

描述: Prostate cancer with matched cancer adjacent tissue array, including pathology grade, TNM, clinical stage, Gleason grade and Gleason scores, 35 cases/76 cores, replacing MPR761

详情: Prostate carcinoma with matched cancer adjacent tissue microarray, containing 35 cases of adenocarcinoma with 3 matched cancer adjacent tissue, single cores per block

应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Prostate
  • AT(-)
  • Malignant()
  • Malignant(I)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(III)
  • Malignant(IV)
组织芯片
MPR761a
1
2
3
4
5
6
7
8
9
10
A
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
B
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
C
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
D
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
E
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
F
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
G
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
Pro
H
Pro
Pro
Pro
Pro
Pro
Pro
MPR761a
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
位置 No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Gleason Grade Gleason Score
A1
1 71 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant - 1 3+3
A2
2 71 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant - 1 2+2
A3
3 66 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*4 I 2+2
A4
4 66 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*4 I 2+2
A5
5 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 3 4+3
A6
6 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 3 4+3
A7
7 68 M Prostate Adenocarcinoma - T2bN0M0 IIB Malignant 8*7*5 1 3+3
A8
8 68 M Prostate Adenocarcinoma - T2bN0M0 IIB Malignant 8*7*5 1 3+3
A9
9 69 M Prostate Adenocarcinoma - T3N0M0 III Malignant 4*3*2 1 3+3
A10
10 69 M Prostate Adenocarcinoma - T3N0M0 III Malignant 4*3*2 1 3+3
B1
11 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 4+5
B2
12 73 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 4+5
B3
13 81 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 6*5*4 3 4+3
B4
14 81 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 6*5*4 3 4+3
B5
15 60 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 1 3+3
B6
16 60 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 1 3+3
B7
17 73 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*3.5*3 2 3+4
B8
18 73 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*3.5*3 2 3+4
B9
19 69 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 6*6*4.5 4 4+4
B10
20 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 6*6*4.5 4 4+4
C1
21 60 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 3*3*3 5 5+5
C2
22 61 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 3*3*3 5 5+5
C3
23 80 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 5+4
C4
24 80 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 5 5+4
C5
25 66 M Prostate Adenocarcinoma - T2N0M0 I Malignant 3*2*1 3 4+3
C6
26 66 M Prostate Adenocarcinoma - T2N0M0 I Malignant 3*2*1 3 4+3
C7
27 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*2*2 3 4+3
C8
28 70 M Prostate Adenocarcinoma - T2aN0M0 IIA Malignant 4*2*2 3 4+3
C9
29 75 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 2 3+4
C10
30 75 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 2 3+4
D1
31 61 M Prostate Adenocarcinoma - T3N1M0 IV Malignant - 4 4+4
D2
32 61 M Prostate Adenocarcinoma - T3N1M0 IV Malignant - 4 4+4
D3
33 62 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*2 4 4+4
D4
34 62 M Prostate Adenocarcinoma - T2N0M0 IIA Malignant 6*5*2 4 4+4
D5
35 70 M Prostate Adenocarcinoma - T3N0M0 III Malignant 7*3*3.5 4 4+4
D6
36 70 M Prostate Adenocarcinoma (sparse) - T3N0M0 III Malignant 7*3*3.5 4 4+4
D7
37 20 M Prostate Adenocarcinoma - T3N0M0 III Malignant 6*5*4 4 4+4
D8
38 20 M Prostate Adenocarcinoma - T3N0M1 III Malignant 6*5*4 4 4+4
D9
39 72 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 5*3*2 5 5+4
D10
40 72 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant 5*3*2 5 5+4
E1
41 72 M Prostate Adenocarcinoma (sparse) - T3N0M0 III Malignant - 4 4+4
E2
42 72 M Prostate Adenocarcinoma - T3N0M0 III Malignant - - -
E3
43 60 M Prostate Adenocarcinoma - T3AN0M0 III Malignant - 5 4+5
E4
44 60 M Prostate Adenocarcinoma - T3AN0M0 III Malignant - 5 4+5
E5
45 74 M Prostate Adenocarcinoma * T2N0M0 II Malignant 6*4*3 - -
E6
46 74 M Prostate Adenocarcinoma - T2N0M0 II Malignant 6*4*3 5 4+5
E7
47 56 M Prostate Adenocarcinoma - T3N0M0 III Malignant 3*2.5 5 4+5
E8
48 56 M Prostate Adenocarcinoma - T3N0M0 III Malignant 3*2.5 5 4+5
E9
49 65 M Prostate Adenocarcinoma - T2N0M0 II Malignant 3*3*2 5 5+4
E10
50 65 M Prostate Adenocarcinoma - T2N0M0 II Malignant 3*3*2 5 5+4
F1
51 60 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 4 5+3
F2
52 60 M Prostate Adenocarcinoma - T3N0M0 III Malignant - 4 5+3
F3
53 75 M Prostate Adenocarcinoma * T2N0M0 Malignant - - -
F4
54 75 M Prostate Adenocarcinoma * T2N0M0 Malignant - - -
F5
55 62 M Prostate Adenocarcinoma - T3N0M0 III Malignant 9*6*2.5 3 4+3
F6
56 62 M Prostate Adenocarcinoma - T3N0M0 III Malignant 9*6*2.5 3 4+3
F7
57 75 M Prostate Adenocarcinoma - T3N1M0 Malignant 5*2*2 5 5+5
F8
58 75 M Prostate Adenocarcinoma - T3N1M0 Malignant 5*2*2 5 5+5
F9
59 63 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 5 5+5
F10
60 63 M Prostate Adenocarcinoma - T2N0M0 II Malignant - 5 5+5
G1
61 66 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 4.5*4*4 5 5+4
G2
62 66 M Prostate Adenocarcinoma - T3aN0M0 III Malignant 4.5*4*4 5 5+4
G3
63 87 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G4
64 87 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G5
65 68 M Prostate Adenocarcinoma (degeneration and necrosis) * T2N0M0 IIA Malignant 5*4*4 - -
G6
66 68 M Prostate Adenocarcinoma (degeneration and necrosis) * T2N0M0 IIA Malignant 5*4*4 - -
G7
67 57 M Prostate Adenocarcinoma * T2aN0M0 IIA Malignant 3*4*4 - -
G8
68 57 M Prostate Adenocarcinoma (sparse) - T2aN0M0 IIA Malignant 3*4*4 4 4+4
G9
69 82 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
G10
70 82 M Prostate Adenocarcinoma - T2N0M0 IIB Malignant - 5 5+4
H1
71 68 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H2
72 68 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H3
73 57 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H4
74 57 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H5
75 82 M Prostate Cancer adjacent prostate tissue - - - AT - - -
H6
76 82 M Prostate Cancer adjacent prostate tissue - - - AT - - -
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们:support@arraysbank.com
0.083275s